News from BrainTrainUK
Neurological Advocacy Service is two years’ old
Neurology Advocacy Service
Society for Neuro-Oncology Meeting
News from the Society for Neuro-Oncology meeting
Are there limitations of headache days used alone as a diagnostic tool?
Enrico Greppi Award at EHF Congress for study supported and funded by Allergan
Novartis data shows treatment with erenumab (AMG 334) cuts migraine days by half
Migraine news from Novartis – Phase III STRIVE study shows positive results
NHS England partners with Merck on a commercial agreement that allows people with MS in England immediate access to cladribine tablets (Mavenclad®)
News from Merck
Veriton Pharma Ltd – New company name for Special Products Ltd
Press release on behalf of Veriton Pharma LtdPublished online: 2/10/17 Veriton Pharma Ltd is announced as the new company name for Special Products Ltd. This name change has occurred both to incorporate the company’s past heritage with its future ambitions to make trusted medicines available for everyday living. The Chief Commercial Officer commented: With the launch of…
XXIII WCN 2017
Highlights from the World Congress of Neurology in Kyoto, Japan
Epistatus® 10 mg Oromucosal Solution Midazolam – Now Available To Prescribe
Press release on behalf of Special Products Ltd
